eMedicine Specialties > Pediatrics: General Medicine > Dermatology

Pyogenic Granuloma

Mark A Crowe, MD, Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine
Brett Steinberg, DO, Staff Physician, Department of Internal Medicine, Walter Reed Army Medical Center

Updated: Oct 13, 2009

Introduction

Background

Pyogenic granulomas (PGs) are benign vascular lesions that occur most commonly on the acral skin of children.1 The term pyogenic granuloma is a misnomer. Originally, these lesions were thought to be caused by bacterial infection; however, the etiology has not been determined. The histopathologic appearance is fairly characteristic; the lesion is, in fact, a lobular capillary hemangioma.

Recognition of pyogenic granuloma as a clinically polypoid or exophytic circumscribed lesion is of importance to the clinician and pathologist because this feature distinguishes pyogenic granulomas from most malignant vascular tumors. Although pyogenic granulomas may be multiple (especially on the skin) and necrosis is common, invasion of adjacent structures is not observed. The lesions grow rapidly and are extremely vascular, frequently bleeding either spontaneously or after minor trauma. They are usually easily treated with surgical removal but may recur.

Uncommon variants include pyogenic granuloma with satellitosis,2,3,4 intravenous pyogenic granulomas,5 subcutaneous pyogenic granulomas,6,7 and eruptive pyogenic granulomas.8,9 Satellite lesions of smaller pyogenic granulomas may develop at the same time as the primary lesion or may occur after attempted treatment of the primary lesion.

Pyogenic granulomas are usually solitary lesions....

Pyogenic granulomas are usually solitary lesions. The fingers and hands are common locations for these to develop. A history of minor trauma at the site shortly before development of the lesion is frequent.



Pyogenic granulomas usually bleed with little or ...

Pyogenic granulomas usually bleed with little or no trauma. This patient shows a positive bandage sign. Because the lesions bleed so easily, patients frequently present with a bandage covering the site.



Pyogenic granulomas usually have a distinct margi...

Pyogenic granulomas usually have a distinct margin that consists of a rim of keratin (dry skin). Notice the moist area of skin produced by the bandage, which was removed shortly before the photograph was taken.



Pyogenic granulomas may be pedunculated and quite...

Pyogenic granulomas may be pedunculated and quite large. An area of necrosis is also common.



Pyogenic granulomas may occur at various sites. M...

Pyogenic granulomas may occur at various sites. More than 60% of all lesions develop on the head and neck.



Small pyogenic granuloma.

Small pyogenic granuloma.


Pathophysiology

Although most patients (74.2%) do not have a history of trauma or predisposing dermatologic conditions, in many cases, a history of recent trauma at the site is present. Large numbers of lesions may occur following damage to diffuse areas skin by burns or other trauma.10,11 A nitric oxide synthase–dependent mechanism is thought to contribute to angiogenesis and the rapid growth of pyogenic granulomas. They are benign vascular proliferations, but the specific pathophysiology of these lesions is unknown.

Frequency

United States

Pyogenic granulomas account for 0.5% of skin lesions in infants and children and are also found in the oral mucosa in 2% of pregnant women.

Mortality/Morbidity

Most pyogenic granulomas are asymptomatic except for mild tenderness and a tendency to bleed with little or no trauma. They are benign and easily treated. Rarely, pyogenic granulomas in unusual sites such as the intestines may result in significant bleeding12,13,14 or other major complications.15

Race

No substantial difference in incidence is found between races.

Sex

One study of 178 patients younger than 17 years reported the male-to-female ratio as 3:2.16 In adults, pyogenic granulomas are more common in females because of pregnancy-related lesions.

Age

Pyogenic granulomas are most common in the first 5 years of life.17

Clinical

History

Patients with pyogenic granulomas (PGs) usually seek care because the lesion has grown rapidly and bleeds easily. Patients or parents may be concerned because the lesion bleeds with little or no trauma; they are frequently concerned that the rapid growth and bleeding may indicate a malignancy.

Important questions include the following:

  • Does the history include trauma at the site prior to development of the lesion? Pyogenic granulomas may occur following minor physical trauma or burns.
  • How long has the lesion been present? Most pyogenic granulomas develop rapidly. The mean duration at the time of diagnosis is approximately 3 months. If the lesion has been present longer than 6 months, the possibility of cutaneous malignancy increases.
  • Does the lesion bleed easily? Almost all pyogenic granulomas bleed easily. If the lesion does not bleed with light rubbing, a diagnosis of pyogenic granuloma is unlikely.
  • What therapy has been used recently? Nevi, warts, or other lesions may have been treated with caustic agents or cryotherapy prior to referral. Such therapy may markedly change the appearance of the original lesion, causing it to mimic a pyogenic granuloma.
  • Is the patient pregnant? Oral pyogenic granulomas can develop during or just after the first trimester of pregnancy. Examine and properly identify these lesions of pregnancy to avoid misdiagnosis and overtreatment. These lesions are not generally harmful in pregnancy; however, induction of labor due to uncontrollable bleeding from a gingival lesion has been reported.18,19,20,21,22,23
  • Has the lesion recurred after surgical treatment? If so, was it excised and the skin closed primarily or was it treated with shave removal and electrodesiccation of the base? Pyogenic granulomas may recur. This is more likely when they are incompletely removed, but recurrence is also possible after apparently complete removal. Pyogenic granulomas are more likely to recur after shave removal and electrodesiccation of the base than after surgical excision.
  • Has the patient taken oral retinoid therapy (isotretinoin [Accutane]) recently? Facial pyogenic granuloma–like lesions during isotretinoin therapy have been reported.

Physical

  • Pyogenic granulomas appear as smooth firm nodules, with or without crusts, and they may have a bright or dusky red color. They are usually solitary, well circumscribed, dome shaped, 1-10 mm in diameter, and sessile or pedunculated.
  • In children, pyogenic granulomas are most commonly located on the head and neck (62.4%) and, in order of decreasing frequency, on the trunk (19.7%), upper extremity (12.9%), and lower extremity (5%). Most (88.2%) occur on the skin, and the rest involve mucous membranes of the oral cavity and conjunctivae.
  • In pregnant women, pyogenic granulomas are most often found on the gingival mucosa20,24 but they have been known to appear in nonoral areas such as the fingers and inguinal crease.
  • Pyogenic granulomas may occur within a port-wine stain; the presence of a vascular birthmark in the region of the pyogenic granuloma may be significant.
  • Amelanotic melanoma may closely mimic a pyogenic granuloma in appearance. Closely examine the skin immediately adjacent to the lesion for any pigmentary irregularity.

Causes

  • Originally, pyogenic granulomas were thought to be caused by bacterial infection; the etiology has yet to be determined. Postulated etiologies include viral, hormonal, and, more recently, angiogenic factors.
  • Pyogenic granulomas have been evaluated for the presence of human papillomavirus (HPV) because warts occur in similar age groups and sites. Lesions were tested for HPV 6, 11, 16, 31, 33, 35, 42, and 58. No viruses were present.
  • Recurrent pyogenic granuloma with satellitosis is an uncommon variant. In one patient with recurrent pyogenic granuloma with satellitosis, Warthin-Starry staining of the lesions revealed clumps of dark bacilli as found in patients with bacillary angiomatosis.2 An indirect immunofluorescence assay showed elevated immunoglobulin G antibodies against Bartonella (Rochalimaea) henselae. The patient did not present an obvious risk for human immunodeficiency virus (HIV) infection or immunosuppression; no antibodies against HIV-1 and HIV-2 were found. Recurrent pyogenic granulomas with satellitosis may be a localized variant of bacillary angiomatosis.

Differential Diagnoses

Other Problems to Be Considered

Amelanotic malignant melanoma
Angiolymphoid hyperplasia with eosinophilia
Bacillary angiomatosis
Basal cell carcinoma
Benign lymphangioendothelioma
Eruptive epithelioid hemangioendothelioma with spindle cells
Facial pyogenic granuloma (PG)-like lesions associated with isotretinoin therapy
Glomeruloid hemangioma
Glomus tumor
Intravascular papillary endothelial hyperplasia
Kaposi sarcoma
Kaposiform hemangioendothelioma
Metastatic carcinoma
Microvenular hemangioma
Spindle-cell hemangioendothelioma
Squamous cell carcinoma
Targetoid hemosiderotic hemangioma
Tufted hemangioma

Workup

Procedures

  • Obtain a biopsy of any lesion suspected of being a pyogenic granuloma (PG) to confirm the diagnosis.

Histologic Findings

  • Proliferation of capillaries is present, with prominent endothelial cells embedded in edematous gelatinous stroma in a characteristic lobular configuration.
  • The epidermis is commonly eroded.
  • A dense infiltrate and granulation tissue with polymorphonuclear leukocytes may be present.
  • Hyperproliferation of the epidermis is usually present at the margins of the vascular growth, which results in a collarette of epidermis.25,16,26

Treatment

Surgical Care

  • Treatment of pyogenic granulomas (PGs) most commonly consists of shave removal and electrocautery or surgical excision with primary closure.27 Removal of the lesion is indicated for bleeding due to trauma, discomfort, cosmetic distress, and diagnostic biopsy. The lesion may be completely removed during biopsy.
  • For solitary lesions, a shave excision and electrocautery under local anesthesia is the treatment of choice. To provide an adequate cure rate, all vascular granulation tissue must be removed or cauterized.
  • For large or recurrent lesions, surgical excision with primary closure may be more effective. One study reported a 43.5% recurrence rate in 23 lesions treated by shave (intradermal) excision and cautery or cautery alone. Lesions treated by full-thickness skin excision and linear closure did not recur.
  • Therapy with the pulsed-dye laser at vascular-specific 585 nm is very selective, usually requires no anesthesia, and produces excellent cosmetic results.28,29 The pulsed-dye laser works quite well for intraoral pyogenic granulomas, as observed in pregnant women. Although treatment is feasible, treatment during pregnancy is not necessary because the lesions may recur during the pregnancy and generally resolve with delivery. Various other lasers have also been shown to be effective in treating pyogenic granulomas.30,31,32,33
  • Cryotherapy or silver nitrate therapy may be effective for very small lesions; however, treatment failure rates are high.34,35
  • In pediatric cases, a eutectic mixture of local anesthetics (EMLA) applied to the lesion and surrounding skin under an occlusive dressing for 1-2 hours prior to additional intralesional anesthesia may be of significant value.

Consultations

  • Consider referral to a dermatologist if the diagnosis is in doubt or if the availability of adequate therapy is questionable.

Medication

  • Despite the necrosis, foul odor, and purulent drainage noted occasionally with pyogenic granulomas (PGs), antibiotic therapy is rarely required.

Follow-up

Further Outpatient Care

  • Following removal of the pyogenic granuloma (PG), routine wound care is the only treatment required.
  • Follow-up visits are required only if the lesion recurs. If the lesion recurs and histopathology confirms the diagnosis, the recurrent lesion may be treated with any of the modalities previously discussed, including simply repeating the initial therapy.

Complications

  • Significant secondary infection (extremely uncommon)
  • Recurrence at the original site
  • Recurrence as multiple satellite lesions in the area immediately surrounding the original lesion
  • Superficial scar formation
  • Oral pyogenic granulomas
    • An oral pyogenic granulomas can develop during or just after the first trimester of pregnancy.
    • Usually, an oral pyogenic granulomas is an early slow-growing mass that, upon excision, does not leave a large defect in the periodontium that requires surgical repair.
    • Rarely, a rapidly growing large tumor may produce significant hemorrhage.

Prognosis

  • Prognosis is excellent after simple removal and wound care.

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose and adequately treat an amelanotic melanoma is the most significant concern.
  • Although amelanotic melanoma is extremely rare in children, histologic examination should always be performed to confirm the diagnosis.

Multimedia

Pyogenic granulomas are usually solitary lesions....

Media file 1: Pyogenic granulomas are usually solitary lesions. The fingers and hands are common locations for these to develop. A history of minor trauma at the site shortly before development of the lesion is frequent.

Pyogenic granulomas usually bleed with little or ...

Media file 2: Pyogenic granulomas usually bleed with little or no trauma. This patient shows a positive bandage sign. Because the lesions bleed so easily, patients frequently present with a bandage covering the site.

Pyogenic granulomas usually have a distinct margi...

Media file 3: Pyogenic granulomas usually have a distinct margin that consists of a rim of keratin (dry skin). Notice the moist area of skin produced by the bandage, which was removed shortly before the photograph was taken.

Pyogenic granulomas may be pedunculated and quite...

Media file 4: Pyogenic granulomas may be pedunculated and quite large. An area of necrosis is also common.

Pyogenic granulomas may occur at various sites. M...

Media file 5: Pyogenic granulomas may occur at various sites. More than 60% of all lesions develop on the head and neck.

Unlike pyogenic granulomas, cherry angiomas such ...

Media file 6: Unlike pyogenic granulomas, cherry angiomas such as these are slow to develop, do not bleed easily, are frequently multiple, are more commonly found on the trunk, and seldom have a history of prior trauma.

Several malignant tumors may mimic pyogenic granu...

Media file 7: Several malignant tumors may mimic pyogenic granulomas. This lesion is a squamous cell carcinoma. Amelanotic melanomas (little or no overt pigment) are also included in the differential diagnosis. These tumors are usually slower growing than pyogenic granulomas and are uncommon in children. Tissue removed as part of the treatment process should be sent for histopathologic examination to confirm the diagnosis.

Small pyogenic granuloma.

Media file 8: Small pyogenic granuloma.

References

  1. Requena L, Sangueza OP. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. Dec 1997;37(6):887-919; quiz 920-2. [Medline].

  2. Itin PH, Fluckiger R, Zbinden R, Frei R. Recurrent pyogenic granuloma with satellitosis--a localized variant of bacillary angiomatosis?. Dermatology. 1994;189(4):409-12. [Medline].

  3. Le Meur Y, Bedane C, Clavere P, et al. A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrol Dial Transplant. Jun 1997;12(6):1271-3. [Medline][Full Text].

  4. Taira JW, Hill TL, Everett MA. Lobular capillary hemangioma (pyogenic granuloma) with satellitosis. J Am Acad Dermatol. Aug 1992;27(2 Pt 2):297-300. [Medline].

  5. Saad RW, Sau P, Mulvaney MP, James WD. Intravenous pyogenic granuloma. Int J Dermatol. Feb 1993;32(2):130-2. [Medline].

  6. Fortna RR, Junkins-Hopkins JM. A case of lobular capillary hemangioma (pyogenic granuloma), localized to the subcutaneous tissue, and a review of the literature. Am J Dermatopathol. Aug 2007;29(4):408-11. [Medline].

  7. Park YH, Houh D, Houh W. Subcutaneous and superficial granuloma pyogenicum. Int J Dermatol. Mar 1996;35(3):205-6. [Medline].

  8. Shah M, Kingston TP, Cotterill JA. Eruptive pyogenic granulomas: a successfully treated patient and review of the literature. Br J Dermatol. Nov 1995;133(5):795-6. [Medline].

  9. Strohal R, Gillitzer R, Zonzits E, Stingl G. Localized vs generalized pyogenic granuloma. A clinicopathologic study. Arch Dermatol. Jun 1991;127(6):856-61. [Medline].

  10. Momeni AZ, Enshaieh S, Sodifi M, Aminjawaheri M. Multiple giant disseminated pyogenic granuloma in three patients burned by boiling milk. Int J Dermatol. Oct 1995;34(10):707-10. [Medline].

  11. Palmero ML, Pope E. Eruptive pyogenic granulomas developing after drug hypersensitivity reaction. J Am Acad Dermatol. May 2009;60(5):855-7. [Medline].

  12. Moffatt DC, Warwryko P, Singh H. Pyogenic granuloma: an unusual cause of massive gastrointestinal bleeding from the small bowel. Can J Gastroenterol. Apr 2009;23(4):261-4. [Medline].

  13. Kuga R, Furuya CK Jr, Fylyk SN, Sakai P. Solitary pyogenic granuloma of the small bowel as the cause of obscure gastrointestinal bleeding. Endoscopy. 2009;41 Suppl 2:E76-7. [Medline].

  14. Malhotra A, Jaganmohan S, Scott LD. Clinical challenges and images in GI. Diagnosis: Gastric pyogenic granuloma. Gastroenterology. Apr 2009;136(4):1168, 1463. [Medline].

  15. Stojsic Z, Brasanac D, Kokai G, Vujovic D, Zivanovic D, Boricic I, et al. Intestinal intussusception due to a pyogenic granuloma. Turk J Pediatr. Nov-Dec 2008;50(6):600-3. [Medline].

  16. Patrice SJ, Wiss K, Mulliken JB. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol. Dec 1991;8(4):267-76. [Medline].

  17. Pagliai KA, Cohen BA. Pyogenic granuloma in children. Pediatr Dermatol. Jan-Feb 2004;21(1):10-3. [Medline].

  18. Wang PH, Chao HT, Lee WL, et al. Severe bleeding from a pregnancy tumor. A case report. J Reprod Med. Jun 1997;42(6):359-62. [Medline].

  19. Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci. Dec 2006;48(4):167-75. [Medline].

  20. Epivatianos A, Antoniades D, Zaraboukas T, et al. Pyogenic granuloma of the oral cavity: comparative study of its clinicopathological and immunohistochemical features. Pathol Int. Jul 2005;55(7):391-7. [Medline].

  21. Sills ES, Zegarelli DJ, Hoschander MM, Strider WE. Clinical diagnosis and management of hormonally responsive oral pregnancy tumor (pyogenic granuloma). J Reprod Med. Jul 1996;41(7):467-70. [Medline].

  22. Silverstein LH, Burton CH Jr, Garnick JJ, Singh BB. The late development of oral pyogenic granuloma as a complication of pregnancy: a case report. Compend Contin Educ Dent. Feb 1996;17(2):192-8; quiz 200. [Medline].

  23. Smulian JC, Rodis JF, Campbell WA, et al. Non-oral pyogenic granuloma in pregnancy: a report of two cases. Obstet Gynecol. Oct 1994;84(4 Pt 2):672-4. [Medline].

  24. Saravana GH. Oral pyogenic granuloma: a review of 137 cases. Br J Oral Maxillofac Surg. Jun 2009;47(4):318-9. [Medline].

  25. Kapadia SB, Heffner DK. Pitfalls in the histopathologic diagnosis of pyogenic granuloma. Eur Arch Otorhinolaryngol. 1992;249(4):195-200. [Medline].

  26. Dictor M, Bendsoe N, Runke S, Witte M. Major basement membrane components in Kaposi's sarcoma, angiosarcoma and benign vascular neogenesis. J Cutan Pathol. Oct 1995;22(5):435-41. [Medline].

  27. Giblin AV, Clover AJ, Athanassopoulos A, Budny PG. Pyogenic granuloma - the quest for optimum treatment: Audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007;60(9):1030-5. [Medline].

  28. Tay YK, Weston WL, Morelli JG. Treatment of pyogenic granuloma in children with the flashlamp-pumped pulsed dye laser. Pediatrics. Mar 1997;99(3):368-70. [Medline][Full Text].

  29. Khandpur S, Sharma VK. Successful treatment of multiple gingival pyogenic granulomas with pulsed-dye laser. Indian J Dermatol Venereol Leprol. May-Jun 2008;74(3):275-7. [Medline].

  30. Meffert JJ, Cagna DR, Meffert RM. Treatment of oral granulation tissue with the flashlamp pulsed dye laser. Dermatol Surg. Aug 1998;24(8):845-8. [Medline].

  31. Powell JL, Bailey CL, Coopland AT, et al. Nd:YAG laser excision of a giant gingival pyogenic granuloma of pregnancy. Lasers Surg Med. 1994;14(2):178-83. [Medline].

  32. Gonzalez S, Vibhagool C, Falo LD Jr, et al. Treatment of pyogenic granulomas with the 585 nm pulsed dye laser. J Am Acad Dermatol. Sep 1996;35(3 Pt 1):428-31. [Medline].

  33. Galeckas KJ, Uebelhoer NS. Successful treatment of pyogenic granuloma using a 1,064-nm laser followed by glycerin sclerotherapy. Dermatol Surg. Mar 2009;35(3):530-4. [Medline].

  34. Quitkin HM, Rosenwasser MP, Strauch RJ. The efficacy of silver nitrate cauterization for pyogenic granuloma of the hand. J Hand Surg [Am]. May 2003;28(3):435-8. [Medline].

  35. Dollery W. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Curettage or silver nitrate for pyogenic granulomas on the hand. J Accid Emerg Med. Mar 1999;16(2):140-1. [Medline].

  36. Bastug DF, Ness DT, DeSantis JG. Bacillary angiomatosis mimicking pyogenic granuloma in the hand: a case report. J Hand Surg [Am]. Mar 1996;21(2):307-8. [Medline].

  37. Cabibi D, Cacciatore M, Viviano E, Guarnotta C, Aragona F. 'Pyogenic granuloma-like Kaposi's sarcoma' on the hands: immunohistochemistry and human herpesvirus-8 detection. J Eur Acad Dermatol Venereol. May 2009;23(5):587-9. [Medline].

  38. Cabibi D, Cacciatore M, Viviano E, Guarnotta C, Aragona F. 'Pyogenic granuloma-like Kaposi's sarcoma' on the hands: immunohistochemistry and human herpesvirus-8 detection. J Eur Acad Dermatol Venereol. Aug 28 2008;[Medline].

  39. Harrington P, O'Kelly A, Trail IA, Freemont AJ. Amelanotic subungual melanoma mimicking pyogenic granuloma in the hand. J R Coll Surg Edinb. Aug 2002;47(4):638-40. [Medline].

  40. Holbe HC, Frosch PJ, Herbst RA. Surgical pearl: ligation of the base of pyogenic granuloma--an atraumatic, simple, and cost-effective procedure. J Am Acad Dermatol. Sep 2003;49(3):509-10. [Medline].

  41. Kim HS, Min JA, Kim HO, Park YM. Basal cell carcinoma of the finger resembling a pyogenic granuloma. J Dermatol. Mar 2009;36(3):174-5. [Medline].

  42. Tursen U, Demirkan F, Ikizoglu G. Giant recurrent pyogenic granuloma on the face with satellitosis responsive to systemic steroids. Clin Exp Dermatol. Jan 2004;29(1):40-1. [Medline].

  43. Zaballos P, Salsench E, Puig S, Malvehy J. Dermoscopy of pyogenic granulomas. Arch Dermatol. Jun 2007;143(6):824. [Medline].

Keywords

pyogenic granuloma, PG, granuloma gravidarum, granuloma telangiectaticum, lobular capillary hemangioma, pregnancy tumor, gingival lesion, exophytic circumscribed lesion, polymorphonuclear leukocytes, satellitosis, intravenous pyogenic granuloma, nevi, warts, port-wine stain, amelanotic melanoma, human papillomavirus, bacillary angiomatosis, polymorphonuclear leukocytes

Contributor Information and Disclosures

Author

Mark A Crowe, MD, Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine
Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society
Disclosure: Nothing to disclose.

Coauthor(s)

Brett Steinberg, DO, Staff Physician, Department of Internal Medicine, Walter Reed Army Medical Center
Brett Steinberg, DO is a member of the following medical societies: American Osteopathic Association
Disclosure: Nothing to disclose.

Medical Editor

Kevin P Connelly, DO, Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University; Medical Director, Paws for Health Pet Visitation Program of the Richmond SPCA; Pediatric Emergency Physician, Emergency Consultants Inc, Chippenham Medical Center
Kevin P Connelly, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

CME Editor

Merrily P M Poth, MD, Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences
Merrily P M Poth, MD is a member of the following medical societies: American Academy of Pediatrics, Endocrine Society, and Lawson-Wilkins Pediatric Endocrine Society
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Further Reading

© 1994- by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)